These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 29697394)

  • 1. SPECIFICITIES OF ENDOMETRIAL PROLIFERATION/STEM CELL INDEX DISTRIBUTION IN ENDOMETRIOID CARCINOMA OF DIFFERENT GRADE OF MALIGNANCY.
    Kikalishvili N; Beriashvili R; Muzashvili T; Burkadze G
    Georgian Med News; 2018 Mar; (276):117-123. PubMed ID: 29697394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AGE-RELATED SPECIFICITIES OF ENDOMETRIAL PROLIFERATION/STEM CELL INDEX DISTRIBUTION.
    Kikalishvili N; Beriashvili R; Muzashvili T; Burkadze G
    Georgian Med News; 2017 Sep; (270):99-104. PubMed ID: 28972492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PROLIFERATIVE/STEM CELL INDEX AND PHENOTYPIC CHARACTERISTICS OF PROLIFERATIVE PROCESSES IN ENDOMETRIUM.
    Kikalishvili N; Beriashvili R; Muzashvili T; Burkadze G
    Georgian Med News; 2018 Sep; (282):156-161. PubMed ID: 30358561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Papillary proliferation of the endometrium: a clinicopathologic study of 59 cases of simple and complex papillae without cytologic atypia.
    Ip PP; Irving JA; McCluggage WG; Clement PB; Young RH
    Am J Surg Pathol; 2013 Feb; 37(2):167-77. PubMed ID: 23211295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of cyclin A in endometrial adenocarcinoma and its correlation with proliferative activity and clinicopathological variables.
    Kyushima N; Watanabe J; Hata H; Jobo T; Kameya T; Kuramoto H
    J Cancer Res Clin Oncol; 2002 Jun; 128(6):307-12. PubMed ID: 12073048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endometrioid endometrial carcinoma with atrophic endometrium and poor prognosis.
    Geels YP; Pijnenborg JM; van den Berg-van Erp SH; Bulten J; Visscher DW; Dowdy SC; Massuger LF
    Obstet Gynecol; 2012 Nov; 120(5):1124-31. PubMed ID: 23090531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pathogenesis of endometrial carcinomas at menopause: facts and figures.
    Sivridis E; Giatromanolaki A
    J Clin Pathol; 2011 Jul; 64(7):553-60. PubMed ID: 21330315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p53 aberrations in low grade endometrioid carcinoma of the endometrium with nodal metastases: possible insights on pathogenesis discerned from immunohistochemistry.
    Fadare O; Parkash V
    Diagn Pathol; 2017 Nov; 12(1):81. PubMed ID: 29137657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can the apparent diffusion coefficient differentiate the grade of endometrioid adenocarcinoma and the histological subtype of endometrial cancer?
    Yan B; Zhao T; Liang X; Niu C; Ding C
    Acta Radiol; 2018 Mar; 59(3):363-370. PubMed ID: 28696169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunolocalization of ERK1/2 and p-AKT in normal endometrium, endometrial hyperplasia, and early and advanced stage endometrioid endometrial adenocancer and their prognostic significance in malignant group.
    Gungorduk K; Ertas IE; Sahbaz A; Ozvural S; Sarica Y; Ozdemir A; Sayhan S; Gokcu M; Yilmaz B; Sanci M; Inan S; Harma M; Yildirim Y
    Eur J Obstet Gynecol Reprod Biol; 2014 Aug; 179():147-52. PubMed ID: 24965996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GLUT-1 Expression in Proliferative Endometrium, Endometrial Hyperplasia, Endometrial Adenocarcinoma and the Relationship Between GLUT-1 Expression and Prognostic Parameters in Endometrial Adenocarcinoma.
    Canpolat T; Ersöz C; Uğuz A; Vardar MA; Altintaş A
    Turk Patoloji Derg; 2016; 32(3):141-7. PubMed ID: 27562387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atypical mucinous glandular proliferations in endometrial samplings: follow-up and other clinicopathological findings in 41 cases.
    Rawish KR; Desouki MM; Fadare O
    Hum Pathol; 2017 May; 63():53-62. PubMed ID: 28232161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Markers of proliferative activity are predictors of patient outcome for low-grade endometrioid adenocarcinoma but not papillary serous carcinoma of endometrium.
    Al Kushi A; Lim P; Aquino-Parsons C; Gilks CB
    Mod Pathol; 2002 Apr; 15(4):365-71. PubMed ID: 11950909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of ovarian hyperthecosis with endometrial polyp, endometrial hyperplasia, and endometrioid adenocarcinoma in postmenopausal women: a clinicopathological study of 238 cases.
    Zhang C; Sung CJ; Quddus MR; Simon RA; Jazaerly T; Lawrence WD
    Hum Pathol; 2017 Jan; 59():120-124. PubMed ID: 27746268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. UbcH10 expression in benign, hyperplastic, and malignant endometrial curetted materials: a tissue microarray study.
    Kefeli M; Yildiz L; Celik H; Tosun M; Karagoz F
    Int J Surg Pathol; 2012 Aug; 20(4):360-6. PubMed ID: 22415060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Matrix metalloproteinases 2 and 9, E-cadherin, and beta-catenin expression in endometriosis, low-grade endometrial carcinoma and non-neoplastic eutopic endometrium.
    Shaco-Levy R; Sharabi S; Benharroch D; Piura B; Sion-Vardy N
    Eur J Obstet Gynecol Reprod Biol; 2008 Aug; 139(2):226-32. PubMed ID: 18295959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of a putative stem cell marker Musashi-1 in endometrium.
    Lu X; Lin F; Fang H; Yang X; Qin L
    Histol Histopathol; 2011 Sep; 26(9):1127-33. PubMed ID: 21751144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New concepts for an old problem: the diagnosis of endometrial hyperplasia.
    Sanderson PA; Critchley HO; Williams AR; Arends MJ; Saunders PT
    Hum Reprod Update; 2017 Mar; 23(2):232-254. PubMed ID: 27920066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of laminin-1 and matrix metalloproteinase-9 in benign and malignant endometrium.
    Küçükaydın Z; Başaran M; Ünlü Y; Başaran A; Kurdoğlu M
    Turk J Med Sci; 2023 Feb; 53(1):149-159. PubMed ID: 36945954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of an immunocytochemical double-labeling staining can display the distribution of Bcl-2/Ki-67 cells in endometrial adenocarcinomas as well as in normal endometrium.
    Mourtzikou A; Kosmas K; Marouga A; Stamouli M; Pouliakis A; Karakitsos P
    Clin Lab; 2012; 58(1-2):133-44. PubMed ID: 22372356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.